Natriumchlorid Deltamedica (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Deltamedica, is an electrolyte presented as an injection solution for intravenous use. It restores extracellular fluid volume and electrolyte balance in patients who need fluid and electrolyte replacement, such as those with dehydration, burns, or postoperative losses.

GNH USA supplies Natriumchlorid Deltamedica as a licensed, GDP‑compliant international pharmaceutical supplier, sourcing the product from the European Union and serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Natriumchlorid Deltamedica, an intravenous electrolyte solution, is used in clinical situations requiring fluid and electrolyte restoration.

- Fluid and electrolyte replacement: restores extracellular fluid volume and corrects electrolyte deficits in patients with dehydration, burns, or surgical losses. - IV hydration: provides isotonic fluid to maintain adequate intravascular volume during surgery or acute illness. - Maintenance of plasma volume: supports plasma oncotic pressure in patients receiving large‑volume resuscitation or ongoing losses.

Natriumchlorid Deltamedica may be associated with the following adverse reactions.

Common Side Effects: - Injection site pain: discomfort at the site of intravenous administration. - Phlebitis: inflammation of the vein used for infusion. - Hypernatremia (if excessive): elevated serum sodium levels. - Hypersensitivity reactions: rash, itching, or mild urticaria.

Serious or Rare Side Effects: - Severe hypernatremia: neurologic symptoms such as confusion or seizures. - Anaphylaxis: rapid, life‑threatening allergic response. - Fluid overload: pulmonary edema or heart failure exacerbation. - Electrolyte imbalance: severe shifts in chloride or sodium causing metabolic disturbances.

Before administering Natriumchlorid Deltamedica, clinicians should consider several safety measures.

- Assess patient fluid status: evaluate volume needs and losses before infusion. - Monitor serum electrolytes: check sodium and chloride levels during therapy. - Use aseptic technique: prevent contamination of the injection solution. - Avoid rapid infusion in at‑risk patients: follow recommended infusion rates. - Renal impairment: adjust volume and rate as needed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Natriumchlorid Deltamedica can interact with other agents that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use may cause severe hypernatremia. - Potassium chloride IV: combined high sodium load can exacerbate fluid overload. - Loop diuretics: may increase sodium loss, requiring careful monitoring.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may affect renal handling of sodium, monitor electrolytes. - Corticosteroids: can increase sodium retention, watch for hypertension. - Colloids or blood products: may alter volume status, monitor fluid balance.